Alchemab Therapeutics vs Spark Therapeutics
Alchemab Therapeutics vs Spark Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alchemab Therapeutics is on 42/100 and Spark Therapeutics on 58/100.
Where each one leads
Alchemab Therapeutics
Leads on none of the measures we hold for both companies.
Spark Therapeutics
- our overall score: 58/100 against 42/100
- domain rating: 80/100 against 33/100
- funding raised: $82.8M against $31.5M
At a glance
| Measure | Alchemab Therapeutics | Spark Therapeutics |
|---|---|---|
| What it is | Discovering and developing first-in-class antibody therapeutics by identifying protective antibodies from disease-resilient individuals. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug Discovery | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2019 | 2013 |
| Headquarters | London, United Kingdom | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alchemab Therapeutics | Spark Therapeutics |
|---|---|---|
| Total funding | $31.5M | $82.8M |
| Latest round | Series A | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alchemab Therapeutics | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 58/100 |
| Traction | 37/100 | 40/100 |
| Team | Not published | 90/100 |
| Search visibility | 8/100 | 13/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (36/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alchemab Therapeutics | Spark Therapeutics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | Alchemab Therapeutics | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
Alchemab Therapeutics vs Spark Therapeutics: common questions
Which is better, Alchemab Therapeutics or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Alchemab Therapeutics and Spark Therapeutics compare on the numbers?
Spark Therapeutics leads on our overall score (58/100 against 42/100), domain rating (80/100 against 33/100), funding raised ($82.8M against $31.5M).
What do real users say about Alchemab Therapeutics and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full Alchemab Therapeutics review and pricing or the Spark Therapeutics review and pricing. You can also browse other Alchemab Therapeutics alternatives we track.